| DNA methyltransferase inhibitors in cancer: from pharmacology to translational studies D Pechalrieu, C Etievant, PB Arimondo Biochemical pharmacology 129, 1-13, 2017 | 115 | 2017 |
| Identification of novel quinazoline derivatives as potent antiplasmodial agents A Bouchut, D Rotili, C Pierrot, S Valente, S Lafitte, J Schultz, U Hoglund, ... European Journal of Medicinal Chemistry 161, 277-291, 2019 | 60 | 2019 |
| Rational design of bisubstrate-type analogues as inhibitors of DNA methyltransferases in cancer cells L Halby, Y Menon, E Rilova, D Pechalrieu, V Masson, C Faux, MA Bouhlel, ... Journal of Medicinal Chemistry 60 (11), 4665-4679, 2017 | 48 | 2017 |
| Synthesis of novel 3-halo-3-nitroflavanones and their activities as DNA methyltransferase inhibitors in cancer cells D Pechalrieu, D Dauzonne, PB Arimondo, M Lopez European Journal of Medicinal Chemistry 186, 111829, 2020 | 31 | 2020 |
| Chemoproteomic profiling by cysteine fluoroalkylation reveals myrocin G as an inhibitor of the nonhomologous end joining DNA repair pathway D Abegg, M Tomanik, N Qiu, D Pechalrieu, A Shuster, B Commare, ... Journal of the American Chemical Society 143 (48), 20332-20342, 2021 | 30 | 2021 |
| Hijacking DNA methyltransferase transition state analogues to produce chemical scaffolds for PRMT inhibitors L Halby, N Marechal, D Pechalrieu, V Cura, DM Franchini, C Faux, F Alby, ... Philosophical Transactions of the Royal Society B: Biological Sciences 373 …, 2018 | 26 | 2018 |
| Clinical antiviral drug arbidol inhibits infection by SARS-CoV-2 and variants through direct binding to the spike protein A Shuster, D Pechalrieu, CB Jackson, D Abegg, H Choe, A Adibekian ACS Chemical Biology 16 (12), 2845-2851, 2021 | 24 | 2021 |
| Combined omics approach identifies gambogic acid and related xanthones as covalent inhibitors of the serine palmitoyltransferase complex DG Hoch, D Abegg, JT Hannich, D Pechalrieu, A Shuster, BG Dwyer, ... Cell chemical biology 27 (5), 586-597. e12, 2020 | 21 | 2020 |
| Chemoproteomics‐Enabled De Novo Discovery of Photoswitchable Carboxylesterase Inhibitors for Optically Controlled Drug Metabolism BG Dwyer, C Wang, D Abegg, B Racioppo, N Qiu, Z Zhao, D Pechalrieu, ... Angewandte Chemie International Edition 60 (6), 3071-3079, 2021 | 12 | 2021 |
| Novel quinoline compounds active in cancer cells through coupled DNA methyltransferase inhibition and degradation C Zwergel, R Fioravanti, G Stazi, F Sarno, C Battistelli, A Romanelli, ... Cancers 12 (2), 447, 2020 | 9 | 2020 |
| Bisubstrate-type chemical probes identify GRP94 as a potential target of cytosine-containing adenosine analogs D Pechalrieu, F Assemat, L Halby, M Marcellin, P Yan, K Chaoui, ... ACS chemical biology 15 (4), 952-961, 2020 | 7 | 2020 |
| Hemisynthetic alkaloids derived from trilobine are antimalarials with sustained activity in multidrug-resistant Plasmodium falciparum F Nardella, I Dobrescu, H Hassan, F Rodrigues, S Thiberge, ... Iscience 26 (2), 2023 | 4 | 2023 |
| Compounds for use in the treatment of mycobacterial infections: a patent evaluation (WO2014049107A1) D Pechalrieu, M Lopez Expert Opinion on Therapeutic Patents 25 (6), 729-735, 2015 | 4 | 2015 |
| Correction: Zwergel et al. Novel Quinoline Compounds Active in Cancer Cells through Coupled DNA Methyltransferase Inhibition and Degradation. Cancers 2020, 12, 447 C Zwergel, R Fioravanti, G Stazi, F Sarno, C Battistelli, A Romanelli, ... Cancers 16 (6), 1230, 2024 | | 2024 |
| Chemoproteomic Profiling Maps Zinc-Dependent Cysteine Reactivity N Qiu, D Pechalrieu, D Abegg, A Adibekian Chemical Research in Toxicology 37 (4), 620-632, 2024 | | 2024 |
| Zwergel et al. Novel Quinoline Compounds Active in Cancer Cells through Coupled DNA Methyltransferase Inhibition and Degradation (vol 12, 447, 2020) C Zwergel, R Fioravanti, G Stazi, F Sarno, C Battistelli, A Romanelli, ... CANCERS 16 (6), 2024 | | 2024 |
| Chemoproteomics-enabled de novo discovery of metallothionein degraders B Racioppo, D Pechalrieu, D Abegg, B Dwyer, A Adibekian MOLECULAR & CELLULAR PROTEOMICS 21 (8), S78-S78, 2022 | | 2022 |
| Chemoproteomic identification and functional characterization of colibactin-modified proteins that drive colorectal cancer progression N Qiu, D Abegg, D Pechalrieu, KM Wernke, SB Herzon, A Adibekian MOLECULAR & CELLULAR PROTEOMICS 21 (8), S52-S52, 2022 | | 2022 |
| Chapter III. Chemoproteomics-Enabled De Novo Discovery of Photoswitchable Carboxylesterase Inhibitors for Optically Controlled Drug Metabolism BG Dwyer, C Wang, D Abegg, B Racioppo, N Qiu, Z Zhao, D Pechalrieu, ... Chemoproteomic Tools for Profiling Bioactive Small Molecules: From De Novo …, 2022 | | 2022 |
| Chemoproteomic Profiling by Cysteine Fluoroalkylation Reveals the DNA Repair Protein XRCC5 as a Functional Target of Myrocin G D Abegg, M Tomanik, N Qiu, D Pechalrieu, A Shuster, B Commare, ... | | 2021 |
